Image For Activity Cover
Podcast: Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy

8/24/2017-   Dr. Nicholas Silvestri interviews Dr. Thomas Brannagan about the article Evaluation of patients with refractory chronic inflammatory demyelinating polyneuropathy. Reasons for therapeutic failure in CIDP are inadequate immunotherapy and alternative diagnoses. Certain clinical and electrophysiological features help to distinguish true CIDP from mimics. Once CIDP is confirmed, optimization of IVIg dosing, addition of corticosteroids, plasmapheresis, or chemotherapy results in consistent improvement. Caution is advised when using response to therapy to diagnose CIDP. Muscle Nerve 55: 476-482, 2017.

Summary
Availability: On-Demand
Cost: FREE
Credit Offered:
No Credit Offered


2621 Superior Drive NW
Rochester, MN

P 507.288.0100

F 507.288.1225

aanem@aanem.org

                   

© 2024 American Association of Neuromuscular & Electrodiagnostic Medicine
Powered By